Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 24 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1796. Clear
Clear
Q1
ARTEMIS POLICY GROUP LLC for SICKLE CELL DISEASE ASSOCIATION OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations, Insurance
View → Q1
THE MCMANUS GROUP for FULCRUM THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income
Health Issues
View → Q1
TERUMO BCT, INC. for TERUMO BCT, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Colorado · House · Senate
Trade (domestic/foreign), Health Issues
View → Q1
OGR for LEAVITT PARTNERS, LLC ON BEHALF OF SICKLE CELL DISEASE PARTNERSHIP
1st Quarter (Jan 1 - Mar 31) 2026 · Michigan · House · $20,000.00 income
Health Issues
View → Q1
INDIGO HILL STRATEGIES for SICK CELLS
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $30,000.00 income
Budget/Appropriations, Health Issues
View → Q4
ARTEMIS POLICY GROUP LLC for SICKLE CELL DISEASE ASSOCIATION OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $20,000.00 income
Budget/Appropriations, Medicare/Medicaid, Health Issues, Insurance
View → Q4
THE MCMANUS GROUP for FULCRUM THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Health Issues
View → Q4
INDIGO HILL STRATEGIES for SICK CELLS
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $30,000.00 income
Budget/Appropriations, Health Issues
View → Q4
TERUMO BCT, INC. for TERUMO BCT, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Colorado · House · Senate
Trade (domestic/foreign), Health Issues
View → Q4
OGR for LEAVITT PARTNERS, LLC ON BEHALF OF SICKLE CELL DISEASE PARTNERSHIP
4th Quarter (Oct 1 - Dec 31) 2025 · Michigan · House · $20,000.00 income
Health Issues
View → Q3
TERUMO BCT, INC. for TERUMO BCT, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Colorado · House · Senate
Trade (domestic/foreign), Health Issues
View → Q3
ARTEMIS POLICY GROUP LLC for SICKLE CELL DISEASE ASSOCIATION OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $20,000.00 income
Budget/Appropriations, Insurance, Health Issues, Medicare/Medicaid
View → Q3
THE MCMANUS GROUP for FULCRUM THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Health Issues
View → Q3
OGR for LEAVITT PARTNERS, LLC ON BEHALF OF SICKLE CELL DISEASE PARTNERSHIP
3rd Quarter (July 1 - Sep 30) 2025 · Michigan · House · $20,000.00 income
Health Issues
View → Q3
INDIGO HILL STRATEGIES for SICK CELLS
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate · $30,000.00 income
Budget/Appropriations, Health Issues
View → Q2
TERUMO BCT, INC. for TERUMO BCT, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Colorado · House · Senate
Trade (domestic/foreign), Health Issues
View → Q2
THE MCMANUS GROUP for FULCRUM THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Health Issues
View → Q2
OGR for LEAVITT PARTNERS, LLC ON BEHALF OF SICKLE CELL DISEASE PARTNERSHIP
2nd Quarter (Apr 1 - June 30) 2025 · Michigan · House · $20,000.00 income
Health Issues
View → Q2
ARTEMIS POLICY GROUP LLC for SICKLE CELL DISEASE ASSOCIATION OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations, Insurance
View → Q1
THE MCMANUS GROUP for FULCRUM THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Health Issues
View → Q1
ARTEMIS POLICY GROUP LLC for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)
1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Insurance, Budget/Appropriations
View → Q1
ARTEMIS POLICY GROUP LLC for SICKLE CELL DISEASE ASSOCIATION OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations
View → Q1
THE NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION for NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Agriculture, Budget/Appropriations, Health Issues, Medicare/Medicaid
View → Q1
TERUMO BCT, INC. for TERUMO BCT, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Colorado · House · Senate
Trade (domestic/foreign), Health Issues
View →

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem